D. Bishara

发表

Adverse Effects of Clozapine in Older Patients: Epidemiology, Prevention and Management

David Taylor, D. Bishara, 2013, Drugs & Aging.

Safe prescribing of physical health medication in patients with dementia

D. Bishara, D. Harwood, 2014, International journal of geriatric psychiatry.

Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis

R. Stewart, M. Molokhia, K. Davis, 2020, Journal of the American Geriatrics Society.

Anticholinergic effect on cognition (AEC) of drugs commonly used in older people

David Taylor, J. Sauer, D. Bishara, 2017, International journal of geriatric psychiatry.

‘Real time’ monitoring of antipsychotic prescribing in patients with dementia: a study using the Clinical Record Interactive Search (CRIS) platform to enhance safer prescribing

R. Stewart, Craig Colling, G. Perera, 2020, BMJ open quality.

Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK

R. Howard, David Taylor, R. Howard, 2009, International journal of geriatric psychiatry.

Antipsychotic monitoring in dementia: quality of completion of antipsychotic monitoring forms in an older adult mental health service

R. Stewart, A. Kolliakou, D. Bishara, 2021, BJPsych Bulletin.

The pharmacological management of Alzheimer's disease

David Taylor, J. Sauer, D. Bishara, 2015 .

The pharmacological management of Alzheimer's disease

D. Bishara, 2010 .

Quality of prescribing for schizophrenia: Evidence from a national audit in England and Wales

M. Crawford, Maxine X. Patel, D. Shiers, 2014, European Neuropsychopharmacology.

Safe prescribing in cognitively vulnerable patients: the use of the anticholinergic effect on cognition (AEC) tool in older adult mental health services

R. Stewart, David Taylor, D. Codling, 2019, BJPsych Bulletin.

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

David Taylor, D. Bishara, C. Kalafatis, 2020, Therapeutic advances in psychopharmacology.

David Taylor, F. Besag, S. Varma, 2011, Therapeutic advances in psychopharmacology.

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting

R. Stewart, D. Bishara, B. Balasundaram, 2022, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

Once-monthly paliperidone injection for the treatment of schizophrenia

D. Bishara, 2010, Neuropsychiatric disease and treatment.

Olanzapine: A Systematic Review and Meta-Regression of the Relationships Between Dose, Plasma Concentration, Receptor Occupancy, and Response

S. Kapur, David Taylor, Maxine X. Patel, 2013, Journal of clinical psychopharmacology.

Upcoming Agents for the Treatment of Schizophrenia

D. Bishara, D. Taylor, 2012, Drugs.

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder

David Taylor, D. Bishara, 2009, Neuropsychiatric disease and treatment.

Aspirin in people with dementia, long-term benefits, and harms: a systematic review

R. Stewart, M. Molokhia, K. Davis, 2021, European Journal of Clinical Pharmacology.

The anticholinergic effect on cognition (AEC) scale—Associations with mortality, hospitalisation and cognitive decline following dementia diagnosis

R. Stewart, David Taylor, G. Perera, 2020, International journal of geriatric psychiatry.

Risperidone long‐acting injection: a 6‐year mirror‐image study of healthcare resource use

V. Cornelius, D. Taylor, D. Bishara, 2009, Acta psychiatrica Scandinavica.

Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia.

R. Stewart, David Taylor, G. Perera, 2021, Journal of the American Medical Directors Association.

Anticholinergic drugs and risk of dementia: Time for action?

M. Orrell, A. Avery, C. Coupland, 2021, Pharmacology research & perspectives.

Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice.

David Taylor, V. Cornelius, A. Thomas, 2009, The Journal of clinical psychiatry.

Safe prescribing of physical health medication in patients with dementia

D. Bishara, D. Harwood, 2014, International journal of geriatric psychiatry.

Sedation‐associated medications at dementia diagnosis, their receptor activity, and associations with adverse outcomes in a large clinical cohort

G. Perera, H. Shetty, R. Stewart, 2022, Journal of the American Medical Directors Association.

Embedding a Quality Framework for medication safety standards in delirium and dementia: A Singapore Study in a geriatric psychiatry liaison service

D. Bishara, B. Balasundaram, M. H. Tun, 2023, Delirium Communications.

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder

David Taylor, D. Bishara, 2009, Neuropsychiatric disease and treatment.

Anticholinergic action is rarely a good thing

D. Bishara, 2023, Therapeutic advances in psychopharmacology.

Managing drugs with anticholinergic activity

D. Bishara, 2023, Drug and Therapeutics Bulletin.